News – Oxford Sciences Innovation

Updates

Retweet on Twitter Oxford Sciences Innovation Retweeted

Professor Adrian Hill is the Director of the Jenner Institute at @UniofOxford and the co-founder of @VaccitechLtd. He sat down with GV's @thulme to reveal the backstory behind the @AstraZeneca @UniofOxford vaccine – http://gv.com/news/vaccitech-adrian-hill-covid-19-vaccine/

Reply on Twitter 1331718612936130560 Retweet on Twitter 133171861293613056021 Like on Twitter 133171861293613056034 Twitter 1331718612936130560

Oxford Sciences Innovation @OSI_Updates·

25 Nov

Congratulations to our portfolio company @refeynit on the closure of their Series A funding round. This amazing team are developing mass photometry technologies - weighing molecules with light. Read more: https://bit.ly/2KxGNqk

Reply on Twitter 1331616551057887234 Retweet on Twitter 13316165510578872343 Like on Twitter 133161655105788723417 Twitter 1331616551057887234

Oxford Sciences Innovation @OSI_Updates·

23 Nov

The Backstory: @VaccitechLtd and its role in co-inventing the Oxford COVID-19 vaccine. Read our blog to learn about the groundbreaking science and research that enabled Oxford scientists to create a safe and effective vaccine in months rather than years: https://bit.ly/370ydYP

Reply on Twitter 1330860549412892676 Retweet on Twitter 133086054941289267614 Like on Twitter 133086054941289267624 Twitter 1330860549412892676

Stay up to date with the OSI community

Refeyn Closes Series A Funding Round, led by Northpond Ventures

The Backstory: Vaccitech and its role in co-inventing the Oxford COVID-19 vaccine

BREAKTHROUGH FOR OXFORD’S COVID VACCINE, CO-INVENTED BY OSI PORTFOLIO COMPANY VACCITECH

Evox Therapeutics launch strategic collaboration with Oxford University to accelerate development of exosome therapies for rare diseases

Mind Foundry raises an additional $13.6 million in Series A funding led by Aioi Nissay Dowa Insurance

The Backstory: Base Genomics and their mission to defeat cancer through early diagnosis

Oxford Sciences Innovation announces the sale of Base Genomics to Exact Sciences

Vaccitech expands management team with hires including CMO and CFO

Notice of Annual General Meeting

Fusion energy can be the most cost competitive source of baseload power, at the same level as renewables

Oxford Sciences Innovation appoints Alexis Dormandy as CEO

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

3 portfolio companies win the NHSX AI in Healthcare Award

SpyBiotech announces their Covid-19 vaccine trials

Biocentury feature: OSI leverages foundational deal with Oxford to build its life sciences portfolio

Celebrating five years of OSI and Oxford’s history of innovation

Meet the Founder: Ilana Wisby, CEO of Oxford Quantum Circuits

The genome only makes sense in 3D, by Lachlan Mackinnon

Orca Computing raises £2.9m in pre-seed funding for photonics quantum computer

Positive Phase 1 readout of Dr Sarah Gilbert covid vaccine

Cybersecurity in the age of quantum: Our investment in PQShield

Evox announces landmark partnerships with pharma giants Takeda and Eli Lilly

Welcome to the portfolio, Base Genomics!

A royal launch of our Grassroots incubator space!

Uciane Scarlett, our Life Sciences principal, on an inclusive biotech sector

Vaccitech CEO Bill Enright on the Oxford Covid-19 vaccine

Ultromics featured in the Wall Street Journal

Introducing the Scientist in Residence

Quantum Motion raises £8m in an oversubscribed Series A led by Inkef Capital

Vaccitech partners with the University of Oxford and AstraZeneca to develop a Covid-19 vaccine

Huma Health (formerly Medopad) acquires Biobeats to develop their mental health capabilities

Niantic acquires 6D.ai to develop their augmented reality platform

Congratulations OMass! Team raises £27.5m in additional Series A funding

Patrick Pichette to step down from OSI board, Chris Chambers announced as new chair

Latent Logic acquired by Waymo. Congratulations to the team!

MiroBio launches with £27m Series A!

Ten tools every developer should know in 2018 [Diffblue]

Genomics raises £25m as it announces deal with US pharma giant

10 outstanding start-ups from Oxford to watch

15 Machine Learning Companies To Watch In Europe

Navenio raises £9m for its hospital workforce AI platform

NHS to trial Uber-style location service to match up patients, porters and equipment

Updates

Sign up for OSI Quarterly for brief updates.

Follow us:

Connect

Stay up to date